RH1
2,5-DIAZIRIDIN-1-YL-3-(HYDROXYMETHYL)-6-METHYLCYCLOHEXA-2,5-DIENE-1,4-DIONE
Find entries where: RH1
is present as a standalone ligand in 1 entries
Chemical Component Summary | |
---|---|
Name | 2,5-DIAZIRIDIN-1-YL-3-(HYDROXYMETHYL)-6-METHYLCYCLOHEXA-2,5-DIENE-1,4-DIONE |
Identifiers | 2,5-bis(aziridin-1-yl)-3-(hydroxymethyl)-6-methyl-cyclohexa-2,5-diene-1,4-dione |
Formula | C12 H14 N2 O3 |
Molecular Weight | 234.251 |
Type | NON-POLYMER |
Isomeric SMILES | CC1=C(C(=O)C(=C(C1=O)N2CC2)CO)N3CC3 |
InChI | InChI=1S/C12H14N2O3/c1-7-9(13-2-3-13)12(17)8(6-15)10(11(7)16)14-4-5-14/h15H,2-6H2,1H3 |
InChIKey | JKDLOGLNPDVUCX-UHFFFAOYSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 31 |
Chiral Atom Count | 0 |
Bond Count | 33 |
Aromatic Bond Count | 0 |
Drug Info: DrugBank
DrugBank ID | DB04090 |
---|---|
Name | RH-1 |
Groups |
|
Description | RH-1 has been used in trials studying the treatment of Advanced Solid Tumors and Non-Hodgkin's Lymphoma. |
Synonyms |
|
CAS number | 221635-42-3 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
NAD(P)H dehydrogenase [quinone] 1 | MVGRRALIVLAHSERTSFNYAMKEAAAAALKKKGWEVVESDLYAMNFNPI... | unknown |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
PubChem | 394347 |
ChEMBL | CHEMBL1235676 |